The chemical class LRRIQ4 Inhibitors encompasses a group of compounds that target various elements of the serine/threonine phosphatase system and related signaling pathways. These inhibitors play critical roles in modulating cellular functions by influencing the phosphorylation status of key proteins involved in signal transduction, cell cycle regulation, and other essential cellular processes. The two principal inhibitors in this class, Okadaic Acid and Calyculin A, are known for their potent and specific inhibition of the protein phosphatases PP1 and PP2A. By inhibiting these phosphatases, these chemicals can increase the phosphorylation state of numerous substrates, leading to altered cellular functions. This alteration is significant in studying proteins like LRRIQ4, which are predicted to have serine/threonine phosphatase activity and are involved in signal transduction. The inhibition of PP1 and PP2A can provide insight into the role of phosphatases in various signaling pathways and help in understanding the functional aspects of proteins with similar activities.
The other inhibitors listed, such as Staurosporine, Forskolin, LY294002, and U0126, target different aspects of cell signaling. Staurosporine is a well-known broad-spectrum kinase inhibitor, affecting various kinases including serine/threonine kinases. This broad inhibition profile can indirectly influence proteins involved in similar pathways as LRRIQ4. Forskolin, by elevating cAMP levels, can modulate the activity of cAMP-dependent protein kinases, thereby impacting serine/threonine kinase-regulated pathways. LY294002 and U0126 specifically target PI3K and MEK1/2, respectively, highlighting the intricate network of kinases and phosphatases involved in cellular signaling processes. This chemical class, therefore, offers a diverse set of tools for researchers to investigate the complex signaling networks in cells, particularly those involving serine/threonine phosphatases and kinases. By using these inhibitors, scientists can dissect the roles of specific proteins in these networks, contributing to a deeper understanding of cellular mechanisms.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $150.00 $388.00 | 113 | |
A potent, non-selective inhibitor of protein kinases, including serine/threonine kinases, which may indirectly affect LRRIQ4 activity by altering upstream signaling pathways. | ||||||
Okadaic Acid | 78111-17-8 | sc-3513 sc-3513A sc-3513B | 25 µg 100 µg 1 mg | $285.00 $520.00 $1300.00 | 78 | |
A potent inhibitor of protein phosphatases PP1 and PP2A, potentially modifying the phosphatase-dependent signaling pathways that could intersect with LRRIQ4 functions. | ||||||
Calyculin A | 101932-71-2 | sc-24000 sc-24000A sc-24000B sc-24000C | 10 µg 100 µg 500 µg 1 mg | $160.00 $750.00 $1400.00 $3000.00 | 59 | |
Another inhibitor of protein phosphatases PP1 and PP2A, similar to okadaic acid, affecting the broader phosphatase activity landscape. | ||||||
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $76.00 $150.00 $725.00 $1385.00 $2050.00 | 73 | |
An activator of adenylate cyclase, leading to increased cAMP levels, which could modulate serine/threonine kinase activity indirectly impacting LRRIQ4 pathways. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $121.00 $392.00 | 148 | |
A PI3K inhibitor, affecting a key pathway in cell signaling, which might influence LRRIQ4-involved pathways. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $63.00 $241.00 | 136 | |
An inhibitor of MEK1/2, key enzymes in the MAPK/ERK pathway, potentially impacting signaling pathways associated with LRRIQ4. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
A JNK inhibitor, affecting stress-activated protein kinase pathways, which could intersect with LRRIQ4's roles. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $62.00 $155.00 $320.00 | 233 | |
An mTOR inhibitor, influencing a central regulator of cell growth and proliferation, potentially impacting LRRIQ4-related pathways. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $88.00 $342.00 | 284 | |
A p38 MAP kinase inhibitor, possibly affecting inflammatory and stress response pathways related to LRRIQ4. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $66.00 $219.00 $417.00 | 97 | |
A PI3K inhibitor like LY294002, further highlighting the potential impact on pathways where LRRIQ4 might be involved. | ||||||